MACM
AMAG

March Altus Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

March Altus Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-113,079
Closed -$4.82M – 22
2014
Q4 		$4.82M Sell
113,079
-225,644
-67% -$8.15M 2.2% 19
2014
Q3 		$10.8M Buy
338,723
+192,305
+131% +$4.1M 4.3% 11
2014
Q2 		$3.03M Buy
+146,418
New +$2.71M 1.11% 27

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

March Altus Capital Management's AMAG Position: Q1 2015 in Review

March Altus Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2015, closing a stake of 113,079 shares — an estimated $4.82M sold.

March Altus Capital Management first reported a position in AMAG in Q2 2014 and held it in 3 quarters. The position peaked at $10.8M in Q3 2014. 197 funds tracked by Wall St. Rank hold AMAG as of Q1 2015.

  • March Altus Capital Management reported no remaining AMAG Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • March Altus Capital Management sold 113,079 AMAG Pharmaceuticals shares in Q1 2015, an estimated $4.82M.
  • March Altus Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 3 quarters.
  • March Altus Capital Management's AMAG Pharmaceuticals position peaked at $10.8M in Q3 2014.
  • 197 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2015.

Based on March Altus Capital Management's 13F filing for Q1 2015, filed 15 May 2015.